TKBIF
Price:
$23.2
Market Cap:
$98.38B
Takara Bio Inc., together with its subsidiaries, engages in bioindustry, contract development and manufacturing organization (CDMO), and gene therapy businesses in Japan, China, rest of Asia, the United States, Europe, and internationally. The company sells reagents and instruments, including genetic research reagents and testing kits; products related to coronavirus testing comprising in vitro diagnostics that detect viruses; analytical reagents; single-cell analysis systems; gene expression research reagents; fluorescent proteins series; genome-editing research reagents; iPS cell research reagents; and products for stem cell culturing and induction of differentiation under the TaKaRa, Clon...[Read more]
Industry
Biotechnology
IPO Date
2020-04-27
Stock Exchange
PNK
Ticker
TKBIF
According to Takara Bio Inc.’s latest financial reports and current stock price. The company's current ROE is -0.05%. This represents a change of 28.15% compared to the average of -0.04% of the last 4 quarters.
The mean historical ROE of Takara Bio Inc. over the last ten years is 7.05%. The current -0.05% ROE has changed -100.66% with respect to the historical average. Over the past ten years (40 quarters), TKBIF's ROE was at its highest in in the June 2021 quarter at 7.49%. The ROE was at its lowest in in the December 2024 quarter at -1.74%.
Average
7.05%
Median
4.74%
Minimum
1.33%
Maximum
20.70%
Discovering the peaks and valleys of Takara Bio Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 124.09%
Maximum Annual ROE = 20.70%
Minimum Annual Increase = -90.70%
Minimum Annual ROE = 1.33%
Year | ROE | Change |
---|---|---|
2024 | 1.33% | -90.70% |
2023 | 14.27% | -31.08% |
2022 | 20.70% | 60.87% |
2021 | 12.87% | 124.09% |
2020 | 5.74% | 0.53% |
2019 | 5.71% | 51.34% |
2018 | 3.78% | 67.21% |
2017 | 2.26% | 1.56% |
2016 | 2.22% | 37.45% |
2015 | 1.62% | -37.21% |
The current ROE of Takara Bio Inc. (TKBIF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
12.10%
5-year avg
10.98%
10-year avg
7.05%
Takara Bio Inc.’s ROE is
Company | ROE | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Takara Bio Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Takara Bio Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Takara Bio Inc.'s ROE?
How is the ROE calculated for Takara Bio Inc. (TKBIF)?
What is the highest ROE for Takara Bio Inc. (TKBIF)?
What is the 3-year average ROE for Takara Bio Inc. (TKBIF)?
What is the 5-year average ROE for Takara Bio Inc. (TKBIF)?
How does the current ROE for Takara Bio Inc. (TKBIF) compare to its historical average?